Apomorphine salts, their formulations and use thereof

TW202639125APending Publication Date: 2026-10-01ALAR PHARMA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114142352
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-31
Filing Date
2025-10-31
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078412_001
    Figure TWG2TA001078412_001
  • Figure TWG2TA001078412_002
    Figure TWG2TA001078412_002
  • Figure TWG2TA001078412_003
    Figure TWG2TA001078412_003
Patent Text Reader

Abstract

Provided are very slightly soluble salts of apomorphine, sustained-release pharmaceutical compositions including the slightly or very slightly soluble salts of apomorphine, and their uses in treating a neurological disease, sexual dysfunction, neuroleptic (-like) malignant syndrome, or an alcohol-related disorder. The very slightly soluble salts of apomorphine are an apomorphine hydroxynaphthoate salt or an apomorphine pamoate salt in a crystal or amorphous form. Also provided are methods for preparing the very slightly soluble salt of apomorphine and its crystal or amorphous form.
Need to check novelty before this filing date? Find Prior Art